In vitro and in vivo secretion of human ISG15, an IFN-induced immunomodulatory cytokine - PubMed (original) (raw)
. 1996 Nov 1;157(9):4100-8.
Affiliations
- PMID: 8892645
In vitro and in vivo secretion of human ISG15, an IFN-induced immunomodulatory cytokine
J D'Cunha et al. J Immunol. 1996.
Abstract
ISG15, a 15-kDa protein of unique primary amino acid sequence, functions intracellularly as a ubiquitin homologue and a cytokine that induces production of IFN-gamma and augments NK/lymphokine-activated killer cell proliferation and function. ISG15 is secreted from monocytes and lymphocytes, and in this study we have characterized in vitro and in vivo production of ISG15 in response to IFN-alphabeta. Low levels of ISG15 were present constitutively in PBMCs; dose-dependent ISG15 synthesis was observed in response to IFN-alpha or IFN-beta, but not IFN-gamma. High m.w. conjugates, present in PBMC extracts constitutively, were enhanced after IFN-alpha or IFN-beta treatment. Metabolic labeling experiments demonstrated that IFN-beta-induced ISG15 was released from primary cultures of peripheral blood CD3+ (including both CD4+ and CD8+ subpopulations). Furthermore, ISG15 was released from viable cell lines of monocyte, T lymphocyte, B lymphocyte, and epithelial origins. Since ISG15 was secreted in response to IFN treatment in vitro, its levels in the serum of healthy human volunteers treated with IFN-beta(ser) were quantitated by asymmetric sandwich ELISA. Both single and multiple doses of IFN-beta(ser) increased serum ISG15 levels significantly (p < 0.01) over baseline. A maximum 7.3-fold enhancement of serum ISG15 was obtained after multiple injections of 8 million units of IFN-beta(ser). Significant change was observed at 24 and 48 h of multiple 0.02-million-unit injections, yielding 1.2- and 1.7-fold increases over basal levels, respectively. These studies suggest that ISG15 is a novel member of the cytokine cascade that is synthesized and released in response to IFN-beta both in vitro and in vivo.
Similar articles
- Immunoregulatory properties of ISG15, an interferon-induced cytokine.
D'Cunha J, Knight E Jr, Haas AL, Truitt RL, Borden EC. D'Cunha J, et al. Proc Natl Acad Sci U S A. 1996 Jan 9;93(1):211-5. doi: 10.1073/pnas.93.1.211. Proc Natl Acad Sci U S A. 1996. PMID: 8552607 Free PMC article. - Production of ISG-15, an interferon-inducible protein, in human corneal cells.
Taylor JL, D'Cunha J, Tom P, O'Brien WJ, Borden EC. Taylor JL, et al. J Interferon Cytokine Res. 1996 Nov;16(11):937-40. doi: 10.1089/jir.1996.16.937. J Interferon Cytokine Res. 1996. PMID: 8938569 - Molecular cloning of the fish interferon stimulated gene, 15 kDa (ISG15) orthologue: a ubiquitin-like gene induced by nephrotoxic damage.
Liu M, Reimschuessel R, Hassel BA. Liu M, et al. Gene. 2002 Oct 2;298(2):129-39. doi: 10.1016/s0378-1119(02)00932-0. Gene. 2002. PMID: 12426101 - Beyond ISGlylation: Functions of Free Intracellular and Extracellular ISG15.
Dos Santos PF, Mansur DS. Dos Santos PF, et al. J Interferon Cytokine Res. 2017 Jun;37(6):246-253. doi: 10.1089/jir.2016.0103. Epub 2017 May 3. J Interferon Cytokine Res. 2017. PMID: 28467275 Review. - ISG15: leading a double life as a secreted molecule.
Bogunovic D, Boisson-Dupuis S, Casanova JL. Bogunovic D, et al. Exp Mol Med. 2013 Apr 12;45(4):e18. doi: 10.1038/emm.2013.36. Exp Mol Med. 2013. PMID: 23579383 Free PMC article. Review.
Cited by
- Protein ISGylation: a posttranslational modification with implications for malignant neoplasms.
Tecalco-Cruz AC, Zepeda-Cervantes J. Tecalco-Cruz AC, et al. Explor Target Antitumor Ther. 2023;4(4):699-715. doi: 10.37349/etat.2023.00162. Epub 2023 Aug 31. Explor Target Antitumor Ther. 2023. PMID: 37711589 Free PMC article. Review. - An MVA-based vector expressing cell-free ISG15 increases IFN-I production and improves HIV-1-specific CD8 T cell immune responses.
Falqui M, Perdiguero B, Coloma R, Albert M, Marcos-Villar L, McGrail JP, Sorzano CÓS, Esteban M, Gómez CE, Guerra S. Falqui M, et al. Front Cell Infect Microbiol. 2023 May 29;13:1187193. doi: 10.3389/fcimb.2023.1187193. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37313341 Free PMC article. - The Functional Roles of ISG15/ISGylation in Cancer.
Yuan Y, Qin H, Li H, Shi W, Bao L, Xu S, Yin J, Zheng L. Yuan Y, et al. Molecules. 2023 Jan 31;28(3):1337. doi: 10.3390/molecules28031337. Molecules. 2023. PMID: 36771004 Free PMC article. Review. - The diverse repertoire of ISG15: more intricate than initially thought.
Kang JA, Kim YJ, Jeon YJ. Kang JA, et al. Exp Mol Med. 2022 Nov;54(11):1779-1792. doi: 10.1038/s12276-022-00872-3. Epub 2022 Nov 1. Exp Mol Med. 2022. PMID: 36319753 Free PMC article. Review. - ISGylation is induced in neurons by demyelination driving ISG15-dependent microglial activation.
Clarkson BDS, Grund E, David K, Johnson RK, Howe CL. Clarkson BDS, et al. J Neuroinflammation. 2022 Oct 20;19(1):258. doi: 10.1186/s12974-022-02618-4. J Neuroinflammation. 2022. PMID: 36261842 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials
Miscellaneous